000 | 02001 a2200637 4500 | ||
---|---|---|---|
005 | 20250517184050.0 | ||
264 | 0 | _c20190724 | |
008 | 201907s 0 0 eng d | ||
022 | _a1592-8721 | ||
024 | 7 |
_a10.3324/haematol.2017.171884 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Swart, Louise | |
245 | 0 | 0 |
_aLabile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. _h[electronic resource] |
260 |
_bHaematologica _c01 2018 |
||
300 |
_a69-79 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 |
_aBlood Transfusion _xmethods |
650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIron _xmetabolism |
650 | 0 | 4 |
_aIron Overload _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyelodysplastic Syndromes _xblood |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProportional Hazards Models |
700 | 1 | _aReiniers, Chloé | |
700 | 1 | _aBagguley, Timothy | |
700 | 1 | _avan Marrewijk, Corine | |
700 | 1 | _aBowen, David | |
700 | 1 | _aHellström-Lindberg, Eva | |
700 | 1 | _aTatic, Aurelia | |
700 | 1 | _aSymeonidis, Argiris | |
700 | 1 | _aHuls, Gerwin | |
700 | 1 | _aCermak, Jaroslav | |
700 | 1 | _avan de Loosdrecht, Arjan A | |
700 | 1 | _aGarelius, Hege | |
700 | 1 | _aCulligan, Dominic | |
700 | 1 | _aMacheta, Mac | |
700 | 1 | _aSpanoudakis, Michail | |
700 | 1 | _aPanagiotidis, Panagiotis | |
700 | 1 | _aKrejci, Marta | |
700 | 1 | _aBlijlevens, Nicole | |
700 | 1 | _aLangemeijer, Saskia | |
700 | 1 | _aDroste, Jackie | |
700 | 1 | _aSwinkels, Dorine W | |
700 | 1 | _aSmith, Alex | |
700 | 1 | _ade Witte, Theo | |
773 | 0 |
_tHaematologica _gvol. 103 _gno. 1 _gp. 69-79 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2017.171884 _zAvailable from publisher's website |
999 |
_c27773709 _d27773709 |